In order to create the next growth curve, pharmaceutical machine companies are deploying in many fields

Pharmaceutical equipment is the equipment used to make medicines and belongs to the upstream of the pharmaceutical industry
.
In recent years, with the rapid development of the pharmaceutical industry, the entire pharmaceutical equipment industry has also ushered in a period of opportunity, and its performance has continued to improve
.
This can be clearly seen from the 2021 performance forecasts that have been disclosed by a large number of pharmaceutical machine companies
.
It is reported that Chutian Technology's 2021 performance forecast shows that net profit growth is expected to reach 149.
33%-199.
20%, Tofflon expects net profit to increase by 65%-95%, and Tailin Biological expects performance to rise in the same direction.
.
.
Pharmaceutical machine companies are increasing However, it is worth noting that with the continuous development of the pharmaceutical industry, the competition in the pharmaceutical equipment industry continues to intensify
.
At present, in order to create the next growth curve and usher in more development opportunities, many pharmaceutical equipment companies have begun to take action and expand their layout in many pharmaceutical fields
.
Among them, the field of biomedicine is undoubtedly the focus of the layout of many pharmaceutical machine companies
.
It is understood that the biopharmaceutical industry, as one of China's strategic emerging industries, is continuously being supported by favorable policies
.
The industry generally believes that the future development prospects of this market will be very broad
.
At present, many pharmaceutical machine companies have firmed their determination to enter or increase the layout of pharmaceutical equipment, especially the field of biopharmaceutical equipment
.
The author has learned that the construction of industrialization projects of many pharmaceutical machine enterprises is in full swing
.
For example, it has been reported before that the R&D and industrialization project of disposable equipment/consumables with a total investment of 200 million yuan for Bailinke Pharmaceutical Machinery has been completed and put into operation at present, and the average annual R&D investment will reach 10%.
% or more
.
In addition, Phase V expansion products and service workshops are scheduled to be put into production in the first quarter of 2022
.
It is reported that the company's self-developed products have broken through the "stuck neck" technology
.
In addition, Chutian Technology has already established Chutian Microspheres and Usite to accelerate its layout in the field of biotechnology
.
In addition to the field of biomedicine, with the support of favorable policies, coupled with technological upgrading and capital increase, the CGT industry is also ushering in rapid development
.
At the same time, the demand for upstream pharmaceutical equipment has also begun to expand
.
Therefore, many pharmaceutical machine companies have also followed the development trend of the industry and are actively innovating and upgrading production processes and pharmaceutical processes
.
It is reported that Tofflon recently disclosed the plan for issuing A shares to specific objects in 2022, which shows that the number of shares to be non-publicly issued to no more than 35 specific investors does not exceed 188,501,112 shares (not exceeding the total share capital of the company before this issuance).
30%), it is planned to raise no more than 3.
2 billion yuan, mainly for the enrichment of the front-end product line (DS) of biopharmaceuticals and cell gene therapy, and the innovation and upgrading and expansion of the injection production line (DP)
.
After the project is completed, it will further enhance the production capacity of the company's core equipment for complex preparation preparation, extend the industrial chain, build an integrated industrial ecology of CGT pharmaceutical equipment, instruments and consumables, and at the same time assist in talent introduction, digital intelligence and internationalization capabilities
.
In addition to the above fields, the traditional Chinese medicine industry is also one of the fields that pharmaceutical machine companies have vigorously developed in recent years
.
At present, many domestic equipment companies, university laboratories, and research institutes have carried out a lot of research work on the efficiency, energy saving, and intelligence of traditional Chinese medicine pharmaceutical equipment, and accelerated technological innovation and improvement of equipment
.
At present, some companies have achieved some success
.
In general, in order to create the next growth curve and obtain more development opportunities, a large number of pharmaceutical equipment companies are deploying in various aspects of the pharmaceutical field with broad market development prospects
.
In this context, the industry expects that related equipment companies will strengthen technical research around pharmaceutical-related links, and will also develop more automated, intelligent, quality and efficiency, energy-saving and consumption-reducing pharmaceutical equipment, and further help more and more companies to improve Production technology level, optimize product production process, and develop in the direction of high quality
.